Search Results

MBX Biosciences, Inc. today announced the appointment of Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (CMO).

Precision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski , M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical Readiness.

Tyra Biosciences, Inc., a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor biology, announced changes to its Board of Directors with the appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as independent directors, and the resignation of Isan Chen, M.D.

MBX Biosciences, Inc. today announced the appointment of Steven Ryder, M.D., Chief Medical Officer of Rallybio, to its Board of Directors.

Tome Biosciences, Inc., the programmable genomic integration company, announces the appointment of Daniel Curran, MD, to its Board of Directors.

Xilio Therapeutics, Inc. announced the appointment of Aoife Brennan, M.D., and James Shannon, M.D., to the company’s board of directors.

Carbon Biosciences announced the appointment of Carol Ann Satler MD, PhD, FACC, FAHA, FAAP to the Carbon Biosciences Board of Directors, and Lloyd Klickstein, MD, PhD to the Scientific Advisory Board.